[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 4th Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
Press Release
March 30, 2022 from 2pm to 4pm
Given the impact of COVID-19, the conference was held online.
Agenda / List of Handouts
Agenda
- Prewriting the Assigned Parts of the Report on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes to Members
- Others
List of Handouts
- Document 1 Summary of Discussions at the 2nd Working Group
- Document 2 Presentation material on Purification Method
- Document 3 Draft Report (Integrated Version)